ES450681A1 - Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol. - Google Patents

Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.

Info

Publication number
ES450681A1
ES450681A1 ES450681A ES450681A ES450681A1 ES 450681 A1 ES450681 A1 ES 450681A1 ES 450681 A ES450681 A ES 450681A ES 450681 A ES450681 A ES 450681A ES 450681 A1 ES450681 A1 ES 450681A1
Authority
ES
Spain
Prior art keywords
methyl
phenyl
blocade
butylaminopropoxy
adrenoceptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES450681A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES450681A1 publication Critical patent/ES450681A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES450681A 1975-08-15 1976-08-13 Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol. Expired ES450681A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1071475 1975-08-15

Publications (1)

Publication Number Publication Date
ES450681A1 true ES450681A1 (es) 1977-11-16

Family

ID=4366041

Family Applications (1)

Application Number Title Priority Date Filing Date
ES450681A Expired ES450681A1 (es) 1975-08-15 1976-08-13 Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.

Country Status (28)

Country Link
US (1) US4434176A (enExample)
JP (2) JPS5223073A (enExample)
AT (1) AT363070B (enExample)
AU (1) AU505719B2 (enExample)
BE (1) BE845197R (enExample)
CA (1) CA1080720A (enExample)
CY (1) CY1225A (enExample)
DE (1) DE2635209C2 (enExample)
DK (1) DK152120C (enExample)
ES (1) ES450681A1 (enExample)
FI (1) FI63751C (enExample)
FR (1) FR2320743A2 (enExample)
GB (2) GB1575509A (enExample)
HK (1) HK35884A (enExample)
IE (1) IE43797B1 (enExample)
IL (2) IL50263A (enExample)
KE (1) KE3404A (enExample)
MY (1) MY8500135A (enExample)
NL (2) NL176362C (enExample)
NO (1) NO762735L (enExample)
NZ (1) NZ181764A (enExample)
PH (1) PH13356A (enExample)
PT (1) PT65477B (enExample)
SE (1) SE414633B (enExample)
SG (1) SG84883G (enExample)
SU (1) SU649313A3 (enExample)
YU (1) YU198876A (enExample)
ZA (1) ZA764883B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
JPS58106499A (ja) * 1981-12-19 1983-06-24 株式会社東芝 燃料交換装置のクランプ解除機構
NL8600137A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten.
US5174210A (en) * 1990-04-27 1992-12-29 Heidelberger Druckmaschinen Aktiengesellschaft Preparation of the inking unit of a printing press for a change of printing job
EP0750608A1 (en) * 1994-01-28 1997-01-02 Cal International Limited Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
BRPI0410840A (pt) * 2003-05-30 2006-07-04 Ranbaxy Lab Ltd derivados substituìdos de pirrol, composição farmacêutica contendo os mesmos e processo para sua preparação
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド (3r,5r)−7−[2−(4−フルオロフェニル)−5−イソプロピル−3−フェニル−4−[(4−ヒドロキシメチルフェニルアミノ)カルボニル]−ピロール−1−イル]−3,5−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH532040A (de) * 1970-03-24 1972-12-31 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
SE375771B (enExample) * 1970-09-30 1975-04-28 Sandoz Ag
CH545784A (en) * 1971-01-07 1974-02-15 Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles
CH545783A (en) * 1971-01-07 1974-02-15 Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides

Also Published As

Publication number Publication date
IL50263A0 (en) 1976-10-31
HK35884A (en) 1984-05-04
MY8500135A (en) 1985-12-31
IE43797L (en) 1977-02-15
DE2635209A1 (de) 1977-02-24
BE845197R (fr) 1977-02-14
FR2320743A2 (fr) 1977-03-11
SU649313A3 (ru) 1979-02-25
NL930134I2 (nl) 1996-11-01
GB1575510A (en) 1980-09-24
NL930134I1 (nl) 1993-11-01
PT65477A (fr) 1976-09-01
FI63751C (fi) 1983-08-10
ZA764883B (en) 1978-03-29
IL58163A0 (en) 1979-12-30
SE7608865L (sv) 1977-02-16
JPS5223073A (en) 1977-02-21
FI63751B (fi) 1983-04-29
NL7608902A (nl) 1977-02-17
IE43797B1 (en) 1981-06-03
SE414633B (sv) 1980-08-11
JPS568834B2 (enExample) 1981-02-25
PT65477B (fr) 1978-05-10
YU198876A (en) 1982-05-31
NO762735L (enExample) 1977-02-16
CA1080720A (en) 1980-07-01
AT363070B (de) 1981-07-10
DE2635209C2 (de) 1983-01-27
DK152120C (da) 1988-06-20
ATA602576A (de) 1980-12-15
JPS5649318A (en) 1981-05-02
DK357576A (da) 1977-02-16
NZ181764A (en) 1978-06-20
SG84883G (en) 1985-01-11
IL50263A (en) 1980-06-30
GB1575509A (en) 1980-09-24
KE3404A (en) 1985-02-01
US4434176A (en) 1984-02-28
NL176362B (nl) 1984-11-01
FR2320743B2 (enExample) 1978-11-17
FI762258A7 (enExample) 1977-02-16
CY1225A (en) 1984-04-06
NL176362C (nl) 1985-04-01
PH13356A (en) 1980-03-20
DK152120B (da) 1988-02-01
AU505719B2 (en) 1979-11-29
AU1684176A (en) 1978-02-16

Similar Documents

Publication Publication Date Title
ES2044187T3 (es) Mercapto-4 butiramidas n-mono o n,n-disubstituidas por un radical mono o polihidroxialquilo, y su utilizacion como agentes reductores en un procedimiento para la deformacion permanente del cabello.
NZ508918A (en) 2-(Purin-9-YL)-tetrahydrofuran-3,4-diol derivatives useful for the treatment of inflammation
ES448475A1 (es) Procedimiento de preparacion de derivados triyodados del benceno.
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
ES450681A1 (es) Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.
ES417862A1 (es) Un procedimiento para preparar nuevos derivados de pipera- zina.
ES369571A1 (es) Procedimiento para la preparacion de 1,3,4-tiadiazolil-(2)-ureas..
ES397598A1 (es) Procedimiento para preparar compuestos organicos de azufre.
GB931923A (en) Process for inhibiting metal corrosion
ES389473A1 (es) Un procedimiento de preparacion de derivados de aminocarbo-nil-3 oxazolidinona-2.
ES422886A1 (es) Procedimiento para la produccion de derivados de 2-(1-pipe-racinil) tiazol.
SE7408826L (enExample)
ES331791A1 (es) Procedimiento para la obtencion de poli-n-oxidos.
ES477317A1 (es) Procedimiento para la obtencion de bencilfenoles.
CA1273946C (en) ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES
ES466682A1 (es) Procedimiento para la obtencion de derivados del acido inde-no - 2.1-b-tiopen-2-oxamico
SE7411096L (enExample)
ES459197A1 (es) Procedimiento para preparar esteres oximicos de isonitroso- cianoacetamida.
JPS5545677A (en) 4*55methanoobufadienolideerhamnoside*its manufacture and medicine containing it
ES395530A1 (es) Procedimiento para la preparacion de nuevos derivados de a-cido acrilico.
ES8400406A1 (es) Procedimiento para preparar derivados de indano.
FR2312255B1 (enExample)
IE810782L (en) Thiazole derivatives
ES446329A1 (es) Un procedimiento de preparacion de nuevas acetamidoximas.
ES443200A1 (es) Procedimiento para preparar derivados de indolinol.